[Digital necrosis revealing cold agglutinin disease: Treatment with rituximab]. 2018

T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
Service de dermatologie et allergologie, université Pierre-et-Marie-Curie, Paris VI, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France. Electronic address: tiffany.klejtman@gmail.com.

BACKGROUND Digital necrosis is rarer than lower limb necrosis and constitutes a medical or surgical emergency. Etiological evaluation is required. Cold agglutinin disease is a cause of digital necrosis but diagnosis is difficult. METHODS Herein we report the case of a 57-year-old man presenting recent paroxysmal acrosyndrome of the left hand subsequently complicated by digital necrosis following occupational exposure to cold in his work as a forklift driver. After etiological evaluation, a diagnosis of primary cold agglutinin disease was made. Intravenous rituximab and topical treatment resulted in complete healing. CONCLUSIONS Cold agglutinin disease is a rare type of auto-immune hemolytic anemia. Following exposure to cold, paroxysmal cutaneous signs are frequent. The disease may be either primary or secondary with B-cell lymphoproliferative disorder, auto-immune disease or infection. A thorough workup is required. To date, the treatment combining the best positive response rate and good safety is rituximab in weekly perfusions over a 1-month period.

UI MeSH Term Description Entries
D007145 Immunoglobulin kappa-Chains One of the types of light chains of the immunoglobulins with a molecular weight of approximately 22 kDa. Ig kappa Chains,Immunoglobulins, kappa-Chain,kappa-Immunoglobulin Light Chains,Immunoglobulin kappa-Chain,kappa-Chain Immunoglobulins,kappa-Immunoglobulin Light Chain,kappa-Immunoglobulin Subgroup VK-12,kappa-Immunoglobulin Subgroup VK-21,Chains, Ig kappa,Immunoglobulin kappa Chain,Immunoglobulin kappa Chains,Immunoglobulins, kappa Chain,Light Chain, kappa-Immunoglobulin,Light Chains, kappa-Immunoglobulin,kappa Chain Immunoglobulins,kappa Chains, Ig,kappa Immunoglobulin Light Chain,kappa Immunoglobulin Light Chains,kappa Immunoglobulin Subgroup VK 12,kappa Immunoglobulin Subgroup VK 21,kappa-Chain, Immunoglobulin,kappa-Chains, Immunoglobulin
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal

Related Publications

T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
August 2003, La Revue de medecine interne,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
May 2007, QJM : monthly journal of the Association of Physicians,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
April 2022, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
November 2012, Transfusion,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
October 2001, British journal of haematology,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
January 2014, Indian journal of dermatology, venereology and leprology,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
August 2008, International journal of laboratory hematology,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
May 2006, Anales de medicina interna (Madrid, Spain : 1984),
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
January 2001, Leukemia,
T Klejtman, and B Garel, and P Senet, and L Tribout, and C Bachmeyer, and A Barbaud, and J-B Monfort
January 2010, Annals of hematology,
Copied contents to your clipboard!